Ophthalmic Drugs Market Size to Surpass USD 31,360 Million by 2030 at 7.80% CAGR – Report by Market Research Future (MRFR)

Advertisement

Ophthalmic Drugs Market Trends and Insights by Dosage Form (Eye Drops, Eye Ointments, Eye Solutions, Gels, Capsules & Tablets and others), Product Type (Prescription Drug and OTC Drug), Drug Class (Antibiotics, Anti-Inflammatory, Anti-Glaucoma and others), Indication (Glaucoma, Retinal Disorder, Dry Eye, Eye Allergy and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa), Competitive Market Growth, Size, Share and Forecast to 2030

New York, USA, Nov. 22, 2022 (GLOBE NEWSWIRE) — Ophthalmic Drugs Market Overview:

According to a Comprehensive Research Report by Market Research Future (MRFR), “Ophthalmic Drugs Market Information by Dosage Form, Product Type, Drug Class, Indication, and Region – Forecast till 2030”, the market is anticipated to reach USD 31,360.6 Million by 2030 at 7.80% CAGR during the forecast period 2022-2030.

Market Scope:

Medicines formulated specifically for use in the eye, such as those for cataract, glaucoma, colorblindness, diabetic macular edema, cytomegalovirus (CMV) retinitis, and age-related macular degeneration, are known as ophthalmic drugs (AMD).

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/5753

Report Scope:

Report Attribute Details
Market Size in 2030 USD 31,360.6 Million
CAGR 7.80%
Base Year 2021
Forecast Period 2022-2030
Historical Data 2020
Forecast Units Value (USD Million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Dosage Form, Product Type and Drug Class
Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers In recent years, the trend of using contact lenses over specs has significantly increased
Increasing geriatric population and rising diabetes cases across the world

Competitive Outlook:

Key players are increasing their foothold via new product development, mergers, and partnerships. The major players of the market are:

  • Alcon
  • Johnson & Johnson Services, Inc.
  • Bausch Health
  • Allergan
  • Pfizer, Inc.
  • Bayer AG
  • Santen Pharmaceutical Co. Ltd.
  • Genentech, Inc.
  • Novartis AG
  • Regeneron
  • Merck & Co.
  • Coherus Biosciences, Inc.

Ophthalmic Drugs Market Dynamics:

Market Drivers

The increasing number of people over the age of 65, the prevalence of eye diseases such as glaucoma, cataracts, and macular degeneration, the soaring demand for ophthalmic drugs, and the rise in investment in R&D activities by various healthcare providers are all factors that are propelling the global ophthalmic drugs market forward. A rise in the number of people who want to use state-of-the-art medical facilities and an increase in education on how to avoid and treat eye diseases are driving the industry forward. Major players in the industry and rising healthcare R&D spending both contribute to the growth of the ophthalmic medicine market.

Demand for ophthalmic medications is on the rise, and this growth is being fueled in part by rising healthcare awareness about preventing eye problems and by government programs to study and develop new ophthalmic drug formulations. The segment for retinal disease dominated the global ophthalmic drugs market by type of indication in 2016, and this trend is expected to continue over the forecast period because of the aging population, the prevalence of macular degeneration, and the surge in sales of ophthalmic drugs for the treatment of retinal disease. However, the glaucoma segment is expected to have considerable growth over the forecast period due to rising glaucoma prevalence, rising demand for ophthalmic medications, and increased awareness of glaucoma prevention and treatment.

North America accounted for a sizable share of the global market for ophthalmic pharmaceuticals, and it is expected to maintain its leadership over the projected period due to the region’s growing older population, rising prevalence of eye disease, and government initiatives for eye health.

Market Restraints

The FDA has strict requirements governing the safety and efficacy of compounded ophthalmic medications, and these products must be tested for sterility for more than 14 days. This is the main factor limiting expansion in the ophthalmic medication market.

Growth in the ophthalmic medication sector has been hampered by rising health care costs and economic downturn in numerous emerging countries. Many people in various third-world countries still don’t understand the value of good eyesight and the improved quality of life it can provide. Ophthalmic medication sales potential is hampered by a lack of public knowledge.

Browse In-depth Market Research Report (95 Pages) on Ophthalmic Drugs: https://www.marketresearchfuture.com/reports/ophthalmic-drugs-market-5753

COVID-19 Analysis:

Due to the rise in occurrences of conjunctivitis, often known as pink eye, the COVID-19 outbreak has had a major impact on the ophthalmic medications market. Since the disease is so easily spread, prompt treatment is more important than ever during this epidemic. In addition, doctors recognize conjunctivitis as an eye manifestation of the coronavirus. Lack of proper eye protection greatly contributed to the rapid spread of SARS. The value of the market for ophthalmic medications has increased thanks to these causes.

The demand for ophthalmic medications in healthcare facilities has increased as a result of preventative measures being taken. When logistics return to normal after the second wave, supply chain interruptions diminish.

Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=5753

Ophthalmic Drugs Market Segmentation:

Based on Indication:

Infection or allergy segment is expected to drive the market over the review period.

Based on Type of drugs:

Over the counter drugs segment is slated to acquire substantial growth over the review period.

Based on dosage:

Liquid Ophthalmic drug form is expected to drive the market over the review period.

Based on distribution channels:

Drug stores is slated to acquire substantial growth over the review period.

Ophthalmic Drugs Market Regional Analysis:

At present, almost 41% of the global market for ophthalmic drugs is controlled by North America. Ophthalmic medicine market value has been growing steadily in recent years, thanks to improvements in therapy made possible by the widespread use of anti-inflammatory therapies. Drugs designed to relieve inflammation, such as Corticosteroids, are frequently prescribed to people with dry eye syndrome. Due to its large elderly population, North America is responsible for a sizable portion of the global market. Research and development (R&D) advancements in the health sector are on the rise in various developed countries, North America included, and the introduction of novel ophthalmic pharmaceuticals is one of the primary driving factors in the expansion of the ophthalmic drugs market.

Share your Queries @ https://www.marketresearchfuture.com/enquiry/5753

The Asia-Pacific area, which now has the greatest glaucoma caseload, is also projected to grow at the fastest rate during the forecast period, with a CAGR of 7.1%. A vast patient base, a high disease prevalence, and the establishment of local companies all contribute to Asia and the Pacific’s rapid economic development. The Asia-Pacific area has the most patients, but also the lowest treatment rate. Growth in the region is anticipated to be bolstered by a number of strategic measures being implemented by market participants.

Discover more research Reports on Healthcare Industry, by Market Research Future:

Contact Lenses Market Research Report: Information By Usage (Daily Wear, Extended Wear, and Traditional Wear), By Design (Spherical, Toric, Multifocal, Monovision, and Cosmetic), By Material (Silicone Hydrogel, Hydrogel, Glass Permeable, Hybrid, and Polymethyl Methacrylate (PMMA)), By Type (Opaque Contact Lenses, Enhanced Contact Lenses, and Tinted Contact Lenses), By Application (Conventional, Orthokeratology, and Decorative), By Distribution Channel (Retail Stores, Hospitals & Clinics, and E-Commerce), and Region – Forecast Till 2030

Smart Contact Lenses Market Information, By Application (Continuous Glucose Monitoring, Intraocular Pressure Monitoring), By End User Type (Hospitals, Clinics And Home Care Settings) – Forecast Till 2027

Ophthalmic Drugs and Devices Market: Information by Product (Drugs and Devices), by Treatment (Eye Infections, Allergic Conjunctivitis, Dry Eyes Syndrome, Red Eyes, Inflammation, and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2030

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter

CONTACT: Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More